Replimune
Price & Volume
Stats
See moreOpen | $7.42 |
Previous Close | $7.56 |
Day Range | $7.22-$7.58 |
52W Range | $2.68-$13.24 |
Market Cap | $624.2M |
Shares Short | 16M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$3.73 |
News
See moreYahoo Finance • 25 days ago
Biliary Tract Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 10.1% During the Forecast Period (2025-2034) | DelveInsight
Yahoo Finance • 2 months ago
Replimune Group GAAP EPS of -$0.77 beats by $0.01
Yahoo Finance • 5 months ago
Replimune Presents Late-Breaking Abstract and Additional Posters on RP1 at 40th Annual Meeting of the Society for the Immunotherapy of Cancer (SITC 2025)
Yahoo Finance • 5 months ago
Trending tickers: HSBC, Cleveland-Cliffs, GSI Technology, Beyond Meat and Replimune
About
CEO | Dr. Sushil Patel Ph.D. |
Address | 500 Unicorn Park Drive, Woburn, MA, United States, 01801 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 479 |
